Percutaneous transluminal coronary angioplasty catheter Vesselin
coronaryballoondrug eluting

Percutaneous transluminal coronary angioplasty catheter - Vesselin  - Lepu Medical - coronary / balloon / drug eluting
Percutaneous transluminal coronary angioplasty catheter - Vesselin  - Lepu Medical - coronary / balloon / drug eluting
Percutaneous transluminal coronary angioplasty catheter - Vesselin  - Lepu Medical - coronary / balloon / drug eluting - image - 2
Percutaneous transluminal coronary angioplasty catheter - Vesselin  - Lepu Medical - coronary / balloon / drug eluting - image - 3
Percutaneous transluminal coronary angioplasty catheter - Vesselin  - Lepu Medical - coronary / balloon / drug eluting - image - 4
Percutaneous transluminal coronary angioplasty catheter - Vesselin  - Lepu Medical - coronary / balloon / drug eluting - image - 5
Add to favorites
Compare this product

Characteristics

Application
percutaneous transluminal coronary angioplasty
Area of the body
coronary
Options
balloon, drug eluting
Total length

1,350 mm
(53 in)

Balloon length

Max.: 38 mm
(1.5 in)

Min.: 9 mm
(0.35 in)

Balloon diameter

Max.: 4.5 mm
(0.18 in)

Min.: 2 mm
(0.08 in)

Description

Product overview
  • Vesselin LPCDB series drug-coated coronary balloon catheter for local antiproliferative delivery during percutaneous coronary procedures.


Key specifications
  • Effective catheter length: 135 cm
  • Compatible guidewire: 0.014"
  • Balloon type: semi-compliant


Drug coating and antiproliferative agent
  • Drug: Paclitaxel — lipophilic agent with prolonged tissue residence
  • Drug dose/loading: 3 µg/mm²
  • Drug matrix: Urea (pharmaceutical grade) to promote rapid and efficient drug transfer
  • Coating particle size: 2–3 µm to balance sustained efficacy and low embolic risk
  • In vivo transfer: >90% reported transfer to lesion site during clinical use


Delivery system and markers
  • Rapid-exchange (new generation) delivery platform for simplified handling
  • Platinum radiopaque markers: one at each balloon end for fluoroscopic positioning
  • Spiral-cut hypotube at transition zone to improve pushability and trackability


Indications
  • Stent restenosis
  • Small vessel disease
  • Bifurcation lesions


Product features
  • Improved PEBAX construction for lower crossing profile and enhanced flexibility
  • Semi-compliant balloon design to optimize lesion conformability and retraction
  • High drug-loading uniformity and rapid in vivo release profile
  • Particle sizing and matrix chosen to minimize distal embolization risk
  • Spiral-cut hypotube optimizes transition support and deliverability


Ordering information (catalogue codes)
Format: Diameter (mm) — codes for lengths 9 / 12 / 16 / 20 / 24 / 28 / 31 / 35 / 38 mm
2.0 — LPCDB 20009 | LPCDB 20012 | LPCDB 20016 | LPCDB 20020 | LPCDB 20024 | LPCDB 20028 | LPCDB 20031 | LPCDB 20035 | LPCDB 20038
2.5 — LPCDB 25009 | LPCDB 25012 | LPCDB 25016 | LPCDB 25020 | LPCDB 25024 | LPCDB 25028 | LPCDB 25031 | LPCDB 25035 | LPCDB 25038
2.75 — LPCDB 27009 | LPCDB 27012 | LPCDB 27016 | LPCDB 27020 | LPCDB 27024 | LPCDB 27028 | LPCDB 27031 | LPCDB 27035 | LPCDB 27038
3.0 — / | LPCDB 30012 | LPCDB 30016 | LPCDB 30020 | LPCDB 30024 | LPCDB 30028 | LPCDB 30031 | LPCDB 30035 | LPCDB 30038
3.5 — LPCDB 35009 | LPCDB 35012 | LPCDB 35016 | LPCDB 35020 | LPCDB 35024 | LPCDB 35028 | LPCDB 35031 | LPCDB 35035 | LPCDB 35038
4.0 — / | LPCDB 400012 | LPCDB 400016 | LPCDB 400020 | LPCDB 400024 | LPCDB 400028 | LPCDB 400031 | LPCDB 400035 | LPCDB 400038
4.5 — LPCDB 45009 | LPCDB 45012 | LPCDB 45016 | LPCDB 45020 | LPCDB 45024 | LPCDB 45028 | LPCDB 45031 | LPCDB 45035 | LPCDB 45038

Technical specifications (summary)
  • Effective length: 135 cm
  • Guidewire compatibility: 0.014"
  • Drug: Paclitaxel; loading 3 µg/mm²; matrix: Urea
  • Balloon: semi-compliant; markers: platinum at each balloon end
  • Catheter: rapid-exchange, improved PEBAX shaft, spiral-cut hypotube transition

VIDEO

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.